Altered dendritic cell functions in autoimmune diseases: Distinct and overlapping profiles

Nature Reviews Rheumatology

Volumn 12, Issue 12, 2016, Pages 703-715

  Coutant, Frédéric ^a   Miossec, Pierre ^b  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

^b UNIVERSITÉ DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL COUNT; CELL DAMAGE; CELL FUNCTION; CELL MIGRATION; CELL POPULATION; CELL THERAPY; CELLULAR DISTRIBUTION; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; INFLAMMATORY CELL; MYOSITIS; NONHUMAN; PHAGOCYTOSIS; PHASE 1 CLINICAL TRIAL (TOPIC); PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; BIOLOGICAL THERAPY; CELL MOTION; IMMUNOLOGY; METABOLISM;

CYTOKINE;

ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; CELL MOVEMENT; CELL- AND TISSUE-BASED THERAPY; CYTOKINES; DENDRITIC CELLS; HUMANS; IMMUNE TOLERANCE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MYOSITIS; PHAGOCYTOSIS;

EID: 84988632690     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2016.147     Document Type: Review

References (133)

1. Dalakas M. C. Inflammatory muscle diseases. N. Engl. J. Med. 372, 1734-1747 (2015
2. Hahn B. H. Antibodies to DNA. N. Engl. J. Med. 338, 1359-1368 (1998
3. Harre U., et al. Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J. Clin. Invest. 122, 1791-1802 (2012
4. Koenig M., Fritzler M. J., Targoff I. N., Troyanov Y., & Senécal J. L. Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes. Arthritis Res. Ther. 9, R78 2007
5. Tsokos G. C. Systemic lupus erythematosus in 2015: Cellular and metabolic requirements of effector T cells. Nat. Rev. Rheumatol. 12, 74-76 (2016
6. Petrelli A., & van Wijk F. CD8+ T cells in human autoimmune arthritis: the unusual suspects. Nat. Rev. Rheumatol. 12, 421-428 (2016
7. Malmström V., Venalis P., & Albrecht I. T cells in myositis. Arthritis Res. Ther. 14, 230 (2012
8. Pascual V., Farkas L., & Banchereau J. Systemic lupus erythematosus: all roads lead to type I interferons. Curr. Opin. Immunol. 18, 676-682 (2006
9. Miossec P., & Kolls J. K. Targeting IL-17 and TH17 cells in chronic inflammation. Nat. Rev. Drug Discov. 11, 763-776 (2012
10. Goebels N., et al. Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis. J. Clin. Invest. 97, 2905-2910 (1996
11. Zielinski C. E. Autoimmunity beyond TH17: GM-CSF producing T cells. Cell Cycle 13, 2489-2490 (2014
12. Ganguly D., Haak S., Sisirak V., & Reizis B. The role of dendritic cells in autoimmunity. Nat. Rev. Immunol. 13, 566-577 (2013
13. Guilliams M., et al. Dendritic cells monocytes and macrophages: a unified nomenclature based on ontogeny. Nat. Rev. Immunol. 14, 571-578 (2014
14. Siegal F. P., et al. The nature of the principal type 1 interferon-producing cells in human blood. Science 284, 1835-1837 (1999
15. León B., López-Bravo M., & Ardavín C. Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania. Immunity 26, 519-531 (2007
16. Hammad H., et al. Inflammatory dendritic cells-not basophils-are necessary and sufficient for induction of TH2 immunity to inhaled house dust mite allergen. J. Exp. Med. 207, 2097-2111 (2010
17. Campbell I. K., et al. Differentiation of inflammatory dendritic cells is mediated by NF-κB1-dependent GM-CSF production in CD4 T cells. J. Immunol. Baltim. Md. 186, 5468-5477 (2011
18. Segura E., et al. Human inflammatory dendritic cells induce TH17 cell differentiation. Immunity 38, 336-348 (2013
19. Steinman R. M., Inaba K., Turley S., Pierre P., & Mellman I. Antigen capture processing and presentation by dendritic cells: recent cell biological studies. Hum. Immunol. 60, 562-567 (1999
20. Somersan S., & Bhardwaj N. Tethering and tickling: a new role for the phosphatidylserine receptor. J. Cell Biol. 155, 501-504 (2001
21. Steinman R. M., et al. Dendritic cell function in vivo during the steady state: a role in peripheral tolerance. Ann. NY Acad. Sci. 987, 15-25 (2003
22. Janeway C. A., & Medzhitov R. Innate immune recognition. Annu. Rev. Immunol. 20, 197-216 (2002
23. Gallucci S., Lolkema M., & Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nat. Med. 5, 1249-1255 (1999
24. Gallo P. M., & Gallucci S. The dendritic cell response to classic emerging and homeostatic danger signals. Implications for autoimmunity. Front. Immunol. 4, 138 (2013
25. Walsh K. P., & Mills K. H. Dendritic cells and other innate determinants of T helper cell polarisation. Trends Immunol. 34, 521-530 (2013
26. Segura E., et al. Characterization of resident and migratory dendritic cells in human lymph nodes. J. Exp. Med. 209, 653-660 (2012
27. Schlitzer A., et al. IRF4 transcription factor-dependent CD11b+ dendritic cells in human and mouse control mucosal IL-17 cytokine responses. Immunity 38, 970-983 (2013
28. Yu C. I., et al. Human CD141+ dendritic cells induce CD4+ T cells to produce type 2 cytokines. J. Immunol. Baltim. Md. 1950 193, 4335-4343 (2014
29. Villadangos J. A., & Young L. Antigen-presentation properties of plasmacytoid dendritic cells. Immunity 29, 352-361 (2008
30. Reizis B., Colonna M., Trinchieri G., Barrat F., & Gilliet M. Plasmacytoid dendritic cells: one-trick ponies or workhorses of the immune system? Nat. Rev. Immunol. 11, 558-565 (2011
31. Swiecki M., & Colonna M. The multifaceted biology of plasmacytoid dendritic cells. Nat. Rev. Immunol. 15, 471-485 (2015
32. Moseman E. A., et al. Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells. J. Immunol. Baltim. Md. 1950 173, 4433-4442 (2004
33. Hanabuchi S., et al. Thymic stromal lymphopoietin-activated plasmacytoid dendritic cells induce the generation of FOXP3+ regulatory T cells in human thymus. J. Immunol. Baltim. Md. 1950 184, 2999-3007 (2010
34. Mart?n-Gayo E., Sierra-Filardi E., Corb? A. L., & Toribio M. L. Plasmacytoid dendritic cells resident in human thymus drive natural Treg cell development. Blood 115, 5366-5375 (2010
35. Jongbloed S. L., et al. Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. J. Exp. Med. 207, 1247-1260 (2010
36. Nizzoli G., et al. Human CD1c+ dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T-cell responses. Blood 122, 932-942 (2013
37. H?mont C., Neel A., Heslan M., Braudeau C., & Josien R. Human blood mDC subsets exhibit distinct TLR repertoire and responsiveness. J. Leukoc. Biol. 93, 599-609 (2013
38. Ueno H., Schmitt N., Palucka A. K., & Banchereau J. Dendritic cells and humoral immunity in humans. Immunol. Cell Biol. 88, 376-380 (2010
39. Jego G., Pascual V., Palucka A. K., & Banchereau J. Dendritic cells control B cell growth and differentiation. Curr. Dir. Autoimmun. 8, 124-139 (2005
40. Qi H., Egen J. G., Huang A. Y. C., & Germain R. N. Extrafollicular activation of lymph node B cells by antigen-bearing dendritic cells. Science 312, 1672-1676 (2006
41. MacLennan I., & Vinuesa C. Dendritic cells BAFF and APRIL: innate players in adaptive antibody responses. Immunity 17, 235-238 (2002
42. Kalled S. L., Ambrose C., & Hsu Y. M. The biochemistry and biology of BAFF APRIL and their receptors. Curr. Dir. Autoimmun. 8, 206-242 (2005
43. Gill M. A., et al. Blood dendritic cells and DC-poietins in systemic lupus erythematosus. Hum. Immunol. 63, 1172-1180 (2002
44. Jin O., et al. Systemic lupus erythematosus patients have increased number of circulating plasmacytoid dendritic cells but decreased myeloid dendritic cells with deficient CD83 expression. Lupus 17, 654-662 (2008
45. Cederblad B., et al. Patients with systemic lupus erythematosus have reduced numbers of circulating natural interferon-alpha-producing cells. J. Autoimmun. 11, 465-470 (1998
46. Farkas L., Beiske K., Lund-Johansen F., Brandtzaeg P., & Jahnsen F. L. Plasmacytoid dendritic cells (natural interferon-α/β-producing cells) accumulate in cutaneous lupus erythematosus lesions. Am. J. Pathol. 159, 237-243 (2001
47. Migita K., et al. Reduced blood BDCA-2+ (lymphoid) and CD11c+ (myeloid) dendritic cells in systemic lupus erythematosus. Clin. Exp. Immunol. 142, 84-91 (2005
48. Jongbloed S. L., et al. Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis. Arthritis Res. Ther. 8, R15 2006
49. Page G., & Miossec P. Paired synovium and lymph nodes from rheumatoid arthritis patients differ in dendritic cell and chemokine expression. J. Pathol. 204, 28-38 (2004
50. Reis e Sousa C. Dendritic cells in a mature age. Nat. Rev. Immunol. 6, 476-483 (2006
51. Sozzani S., Vermi W., Del Prete A., & Facchetti F. Trafficking properties of plasmacytoid dendritic cells in health and disease. Trends Immunol. 31, 270-277 (2010
52. Blomberg S., et al. Presence of cutaneous interferon-α producing cells in patients with systemic lupus erythematosus. Lupus 10, 484-490 (2001
53. Fiore N., et al. Immature myeloid and plasmacytoid dendritic cells infiltrate renal tubulointerstitium in patients with lupus nephritis. Mol. Immunol. 45, 259-265 (2008
54. Tucci M., et al. Glomerular accumulation of plasmacytoid dendritic cells in active lupus nephritis: role of interleukin-18. Arthritis Rheum. 58, 251-262 (2008
55. Lebre M. C., et al. Rheumatoid arthritis synovium contains two subsets of CD83-DC-LAMP-dendritic cells with distinct cytokine profiles. Am. J. Pathol. 172, 940-950 (2008
56. Lspez De Padilla C. M., et al. Plasmacytoid dendritic cells in inflamed muscle of patients with juvenile dermatomyositis. Arthritis Rheum. 56, 1658-1668 (2007
57. Cella M., et al. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat. Med. 5, 919-923 (1999
58. Vermi W., et al. Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin. J. Exp. Med. 201, 509-515 (2005
59. Skrzeczynska-Moncznik J., et al. Potential role of chemerin in recruitment of plasmacytoid dendritic cells to diseased skin. Biochem. Biophys. Res. Commun. 380, 323-327 (2009
60. Albanesi C., et al. Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment. J. Exp. Med. 206, 249- 258 (2009
61. Kaneko K., et al. Chemerin activates fibroblast-like synoviocytes in patients with rheumatoid arthritis. Arthritis Res. Ther. 13, R158 2011
62. Eisinger K., et al. Chemerin induces CCL2 and TLR4 in synovial fibroblasts of patients with rheumatoid arthritis and osteoarthritis. Exp. Mol. Pathol. 92, 90-96 (2012
63. Bondue B., Wittamer V., & Parmentier M. Chemerin and its receptors in leukocyte trafficking inflammation and metabolism. Cytokine Growth Factor Rev. 22, 331-338 (2011
64. Eloranta M. L., et al. A possible mechanism for endogenous activation of the type I interferon system in myositis patients with anti-Jo-1 or anti-Ro 52/anti-Ro 60 autoantibodies. Arthritis Rheum. 56, 3112-3124 2007
65. Page G., Chevrel G., & Miossec P. Anatomic localization of immature and mature dendritic cell subsets in dermatomyositis and polymyositis: Interaction with chemokines and Th1 cytokine-producing cells. Arthritis Rheum. 50, 199-208 (2004
66. Liu K., et al. Immune tolerance after delivery of dying cells to dendritic cells in situ. J. Exp. Med. 196, 1091-1097 (2002
67. Morelli A. E., et al. Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: dependence on complement receptors and effect on cytokine production. Blood 101, 611-620 (2003
68. Green D. R., Ferguson T., Zitvogel L., & Kroemer G. Immunogenic and tolerogenic cell death. Nat. Rev. Immunol. 9, 353-363 (2009
69. Cohen P. L., et al. Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J. Exp. Med. 196, 135-140 (2002
70. Leffler J., Bengtsson A. A., & Blom A. M. The complement system in systemic lupus erythematosus: an update. Ann. Rheum. Dis. 73, 1601-1606 (2014
71. Hu C. Y., et al. Genetic polymorphism in milk fat globule-EGF factor 8 (MFG-E8) is associated with systemic lupus erythematosus in human. Lupus 18, 676-681 (2009
72. Barrat F. J., et al. Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J. Exp. Med. 202, 1131-1139 (2005
73. Ramirez-Ortiz Z. G., et al. The scavenger receptor SCARF1 mediates the clearance of apoptotic cells and prevents autoimmunity. Nat. Immunol. 14, 917-926 (2013
74. Asano K., et al. Masking of phosphatidylserine inhibits apoptotic cell engulfment and induces autoantibody production in mice. J. Exp. Med. 200, 459-467 (2004
75. Peng Y., & Elkon K. B. Autoimmunity in MFG-E8-deficient mice is associated with altered trafficking and enhanced cross-presentation of apoptotic cell antigens. J. Clin. Invest. 121, 2221-2241 (2011
76. White S., & Rosen A. Apoptosis in systemic lupus erythematosus. Curr. Opin. Rheumatol. 15, 557-562 (2003
77. Baccala R., Hoebe K., Kono D. H., Beutler B., & Theofilopoulos A. N. TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity. Nat. Med. 13, 543-551 (2007
78. Li H., et al. Interferon-induced mechanosensing defects impede apoptotic cell clearance in lupus. J. Clin. Invest. 125, 2877-2890 (2015
79. Tournadre A., Lenief V., Eljaafari A., & Miossec P. Immature muscle precursors are a source of interferon-β in myositis: role of Toll-like receptor 3 activation and contribution to HLA class I up-regulation. Arthritis Rheum. 64, 533-541 (2012
80. Greter M., et al. GM-CSF controls nonlymphoid tissue dendritic cell homeostasis but is dispensable for the differentiation of inflammatory dendritic cells. Immunity 36, 1031-1046 (2012
81. Reynolds G., et al. Synovial CD4+ T-cell-derived GM-CSF supports the differentiation of an inflammatory dendritic cell population in rheumatoid arthritis. Ann. Rheum. Dis. http://dx.doi.org/10.1136/annrheumdis-2014-206578 (2015
82. Benedetti G., & Miossec P. Interleukin 17 contributes to the chronicity of inflammatory diseases such as rheumatoid arthritis. Eur. J. Immunol. 44, 339-347 (2014
83. Chevrel G., Granet C., & Miossec P. Contribution of tumour necrosis factor α and interleukin (IL) 1β to IL6 production NF-κB nuclear translocation and class I MHC expression in muscle cells: in vitro regulation with specific cytokine inhibitors. Ann. Rheum. Dis. 64, 1257-1262 (2005
84. Chevrel G., et al. Interleukin-17 increases the effects of IL-1β on muscle cells: arguments for the role of T cells in the pathogenesis of myositis. J. Neuroimmunol. 137, 125-133 (2003
85. Benderdour M., et al. Interleukin 17 (IL-17) induces collagenase-3 production in human osteoarthritic chondrocytes via AP-1 dependent activation: differential activation of AP-1 members by IL-17 and IL-1beta. J. Rheumatol. 29, 1262-1272 (2002
86. Pacquelet S., et al. Interleukin 17, a nitric oxide-producing cytokine with a peroxynitrite-independent inhibitory effect on proteoglycan synthesis. J. Rheumatol. 29, 2602-2610 (2002
87. Takayanagi H. Osteoimmunology and the effects of the immune system on bone. Nat. Rev. Rheumatol. 5, 667-676 (2009
88. Hot A., & Miossec P. Effects of interleukin (IL)-17A and IL-17F in human rheumatoid arthritis synoviocytes. Ann. Rheum. Dis. 70, 727-732 (2011
89. Lee S. Y., et al. IL-17-mediated Bcl-2 expression regulates survival of fibroblast-like synoviocytes in rheumatoid arthritis through STAT3 activation. Arthritis Res. Ther. 15, R31 2013
90. Page G., & Miossec P. RANK and RANKL expression as markers of dendritic cell-T cell interactions in paired samples of rheumatoid synovium and lymph nodes. Arthritis Rheum. 52, 2307-2312 (2005
91. Takayanagi H., et al T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ. Nature 408 600-605 2000
92. Rivollier A., et al. Immature dendritic cell transdifferentiation into osteoclasts: a novel pathway sustained by the rheumatoid arthritis microenvironment. Blood 104, 4029-4037 (2004
93. Gilliet M., Cao W., & Liu Y. J. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat. Rev. Immunol. 8, 594-606 (2008
94. Braun D., Caramalho I., & Demengeot J. IFN-α/β enhances BCR-dependent B cell responses. Int. Immunol. 14, 411-419 (2002
95. Le Bon A., et al. Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 14, 461-470 (2001
96. Le Bon A., et al. Cutting edge: enhancement of antibody responses through direct stimulation of B and T cells by type I IFN. J. Immunol. Baltim. Md. 1950 176, 2074-2078 (2006
97. Means T. K., et al. Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J. Clin. Invest. 115, 407-417 (2005
98. Garcia-Romo G. S., et al. Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci. Transl. Med. 3, 73ra20 (2011
99. Lande R., et al. Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci. Transl. Med. 3, 73ra19 (2011
100. Khandpur R., et al. NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci. Transl. Med. 5, 178ra40 (2013
101. Lombardi V., Van Overtvelt L., Horiot S., & Moingeon P. Human dendritic cells stimulated via TLR7 and/or TLR8 induce the sequential production of Il-10, IFN-γ, and IL-17A by naive CD4+ T cells. J. Immunol. Baltim. Md. 182, 3372-3379 (2009
102. Blanco P., Palucka A. K., Gill M., Pascual V., & Banchereau J. Induction of dendritic cell differentiation by IFN-α in systemic lupus erythematosus. Science 294, 1540-1543 (2001
103. Zhang R., et al. Interferon-alpha and interleukin-6 in SLE serum induce the differentiation and maturation of dendritic cells derived from CD34+ hematopoietic precursor cells. Cytokine 50, 195-203 (2010
104. Litinskiy M. B., et al. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat. Immunol. 3, 822-829 (2002
105. MartIn-Fontecha A., et al. Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J. Exp. Med. 198, 615-621 (2003
106. Ohl L., et al. CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity 21, 279-288 (2004
107. Wakim L. M., Waithman J., van Rooijen N., Heath W. R., & Carbone F. R. Dendritic cell-induced memory T cell activation in nonlymphoid tissues. Science 319, 198-202 (2008
108. Tucci M., Ciavarella S., Strippoli S., Dammacco F., & Silvestris F. Oversecretion of cytokines and chemokines in lupus nephritis is regulated by intraparenchymal dendritic cells: a review. Ann. NY Acad. Sci. 1173, 449-457 (2009
109. Page G., Lebecque S., & Miossec P. Anatomic localization of immature and mature dendritic cells in an ectopic lymphoid organ: correlation with selective chemokine expression in rheumatoid synovium. J. Immunol. Baltim. Md. 168, 5333-5341 (2002
110. Noort A. R., et al. Tertiary lymphoid structures in rheumatoid arthritis: NF-κB-inducing kinase-positive endothelial cells as central players. Am. J. Pathol. 185, 1935-1943 (2015
111. Aziz K. E., McCluskey P. J., & Wakefield D. Characterisation of follicular dendritic cells in labial salivary glands of patients with primary Sjfgren syndrome: comparison with tonsillar lymphoid follicles. Ann. Rheum. Dis. 56, 140-143 (1997
112. Manzo A., Bombardieri M., Humby F., & Pitzalis C. Secondary and ectopic lymphoid tissue responses in rheumatoid arthritis: from inflammation to autoimmunity and tissue damage/remodeling. Immunol. Rev. 233, 267-285 (2010
113. Pitzalis C., Kelly S., & Humby F. New learnings on the pathophysiology of RA from synovial biopsies. Curr. Opin. Rheumatol. 25, 334-344 (2013
114. Corsiero E., et al. Role of lymphoid chemokines in the development of functional ectopic lymphoid structures in rheumatic autoimmune diseases. Immunol. Lett. 145, 62-67 (2012
115. Rangel-Moreno J., et al. The development of inducible bronchus-associated lymphoid tissue depends on IL-17. Nat. Immunol. 12, 639-646 (2011
116. Humby F., et al. Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium. PLoS Med. 6, e1 2009
117. Kroot E. J., et al. The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum. 43, 1831-1835 (2000
118. Thomas R. Dendritic cells and the promise of antigen-specific therapy in rheumatoid arthritis. Arthritis Res. Ther. 15, 204 (2013
119. Daniel C., Ploegh H., & von Boehmer H. Antigen-specific induction of regulatory T cells in vivo and in vitro. Methods Mol. Biol. 707, 173-185 (2011
120. Idoyaga J., et al. Specialized role of migratory dendritic cells in peripheral tolerance induction. J. Clin. Invest. 123, 844-854 (2013
121. Benham H., et al. Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patients. Sci. Transl. Med. 7, 290ra87 (2015
122. Hilkens C. M. U., & Isaacs J. D. Tolerogenic dendritic cell therapy for rheumatoid arthritis: where are we now? Clin. Exp. Immunol. 172, 148-157 (2013
123. US National Library of Medicine Autologous Tolerogenic Dendritic Cells for Rheumatoid Arthritis (AutoDECRA) ClinicalTrials.gov [online], https://clinicaltrials.gov/ct2/show/NCT01352858 (2013
124. Rowland S. L., et al. Early transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model. J. Exp. Med. 211, 1977-1991 (2014
125. Sisirak V., et al. Genetic evidence for the role of plasmacytoid dendritic cells in systemic lupus erythematosus. J. Exp. Med. 211, 1969-1976 (2014
126. Merrill J. T., et al. Safety profile and clinical activity of sifalimumab a fully human anti-interferon α monoclonal antibody in systemic lupus erythematosus: a phase I, multicentre double-blind randomised study. Ann. Rheum. Dis. 70, 1905-1913 (2011
127. Petri M., et al. Sifalimumab a human anti-interferon-α monoclonal antibody in systemic lupus erythematosus: a phase I randomized controlled dose-escalation study. Arthritis Rheum. 65, 1011-1021 (2013
128. McBride J. M., et al. Safety and pharmacodynamics of rontalizumab in patients with systemic lupus erythematosus: results of a phase I, placebo-controlled double-blind dose-escalation study. Arthritis Rheum. 64, 3666-3676 (2012
129. Lauwerys B. R., et al. Down-regulation of interferon signature in systemic lupus erythematosus patients by active immunization with interferon α-kinoid. Arthritis Rheum. 65, 447-456 (2013
130. Haniffa M., Collin M., & Ginhoux F. Ontogeny and functional specialization of dendritic cells in human and mouse. Adv. Immunol. 120, 1-49 (2013
131. Segura E., & Amigorena S. Inflammatory dendritic cells in mice and humans. Trends Immunol. 34, 440-445 (2013
132. Lee J., et al. Restricted dendritic cell and monocyte progenitors in human cord blood and bone marrow. J. Exp. Med. 212, 385-399 (2015
133. Breton G., et al. Circulating precursors of human CD1c+ and CD141+ dendritic cells. J. Exp. Med. 212, 401-413 (2015